510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Alaris Safety Male Luer

K053049510(k) TraditionalCleared Jan 12, 200676-day reviewClass II21 CFR 880.5440Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cardinal Health, Alaris Products · FPA Set, Administration, Intravascular

Cleared on Jan 12, 2006 as substantially equivalent to K972527 (Quality System Consulting, 1997) and 1 other predicate after a 76-day review. Its family tree reaches back 2 generations to 1988. 14 later devices descend from it. It has been recalled 3 times.

Decided
Jan 12, 2006
Review
76 days
Class
Class II
Product code
FPA
Recalls
3
Predicates
2

Its longest line of descent runs back 2 generations to K883614 (1988). 6 ancestors in all. 14 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor1997: 1 other ancestor1995: 1 other ancestor1994: 1 other ancestor2023: 3 descendants cleared2012: 1 descendant cleared2007: 1 descendant cleared2009: 2 descendants cleared2010: 1 descendant cleared2014: 1 descendant cleared2017: 1 descendant cleared2022: 1 descendant cleared2024: 1 descendant cleared2025: 2 descendants clearedK883614 · Cytoguard (R) · Survival Technology, Inc. · 1988K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 19971990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 3 other ancestors 1 generation forward: 3 descendants2 generations forward: 2 descendants3 generations forward: 2 descendants4 generations forward: 1 descendant5 generations forward: 1 descendant6 generations forward: 2 descendants7 generations forward: 1 descendant8 generations forward: 2 descendants K972527 · Phaseal, System for Sealed Handling of Chemotherapeutic Agents · Quality System Consulting · 1997K883614 · Cytoguard (R) · Survival Technology, Inc. · 19880+5
  1. Root · 2 generations backK883614 Cytoguard (R)Survival Technology, Inc. · 1988
  2. 1 generation backK972527 Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting · 1997
  3. This deviceK053049 Alaris Safety Male LuerCardinal Health, Alaris Products · 2006
  4. Descendant · cites it directly · 11 of its ownK071108 Texium SyringeCardinal Health, Alaris Products · 2007 · Recalled
  5. Descendant · 2 generations on · 9 of its ownK083152 Equashield SystemPlastmed, Ltd. · 2009
  6. Descendant · 3 generations on · 8 of its ownK091389 Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009
  7. Descendant · 3 generations on · 7 of its ownK101940 Equashield System Protective PlusEquashield Medical, Ltd. · 2010
  8. Descendant · 4 generations on · 6 of its ownK132899 Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2014

Showing 5 of 14 descendants. See all descendants

Descendants cleared per year

2007: 12009: 22010: 12012: 12014: 12017: 12022: 12023: 32024: 12025: 2
2007high 3 (2023) · low 0 (2008)2026

Most influential descendants

Showing 5 of 14 · See all
  • K071108Texium SyringeCardinal Health, Alaris Products · 2007 · cites it directly11descendants
  • K083152Equashield SystemPlastmed, Ltd. · 2009 · 2 generations on9descendants
  • K091389Equalshield Luer Lock Connector PairPlastmed, Ltd. · 2009 · 3 generations on8descendants
  • K101940Equashield System Protective PlusEquashield Medical, Ltd. · 2010 · 3 generations on7descendants
  • K132899Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd. · 2014 · 4 generations on6descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K883614Cytoguard (R)Survival Technology, Inc.1988—
−1K972527Phaseal, System for Sealed Handling of Chemotherapeutic AgentsQuality System Consulting1997—
0 (this device)K053049Alaris Safety Male LuerCardinal Health, Alaris Products2006—
+1K071108Texium SyringeCardinal Health, Alaris Products20071
+2K083152Equashield SystemPlastmed, Ltd.2009—
+3K091389Equalshield Luer Lock Connector PairPlastmed, Ltd.2009—
+3K101940Equashield System Protective PlusEquashield Medical, Ltd.2010—
+4K132899Equashield Closed System Drug Transfer Device (CSTD)Equashield Medical, Ltd.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510
199710
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200710
200920
201010
201210
201410
201710
202210
202330
202410
202520
FIG. 1 — Lineage of K053049, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972527Phaseal, System for Sealed Handling of Chemotherapeutic Agents
Summary page 2
…type and is substantially equivalent to the following predicate devices: PhaSeal System arma AB K972527 9/18/97 CML 1000 ICU Medical, Inc. K051437 8 INTENDED USE The Safety…
Quality System Consulting1997—
*K051437CML 1000
Summary page 2
…icate devices: PhaSeal System arma AB K972527 9/18/97 CML 1000 ICU Medical, Inc. K051437 8 INTENDED USE The Safety Male Luer is intended to provide leak-free handling of…
Icu Medical, Inc.2005—

Also cleared against K972527: 4 other devices →

What descends from it? (14)

See all 14

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K071108Texium SyringeCardinal Health, Alaris Products200711
K223076BD Texium™ Closed Male LuerCare Fusion20231
K121554Q-Flo Closed Male Luer ConnectorUs Fusion, LLC. Dba Truecare Biomedix-USA20120

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
May 12, 2025Class IIZ-1970-2025Process controlSterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay…
May 12, 2025Class IIZ-1973-2025Process controlSterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay…
Aug 30, 2007Not classifiedZ-0218-2008Finished device change controlLeaks: there is a risk of leakage at the female end of the Texium closed male luer (CML) when attached to a spin luer. (NOTE: users who connect the female portion of the Texium closed male luer to fixed (one-piece) male luers on tubing or…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 18 years and passes through 3 companies; a new generation was cleared every 9.0 years on median.
  • 2 of the 6 ancestors have a recall of any class.
  • Of its descendants, K071108 (Cardinal Health, Alaris Products, 2007) has gone furthest, with 11 descendants of its own.
  • 4 other devices also cite its predicate K972527.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The Safety Male Luer is indicated for use when reconstituting, dispensing/ transferring, administering, and disposal of potentially hazardous fluids, such as chemotherapy, radioactive isotopes, and blood products, as well as non-hazardous fluids. The Safety Male Luer is intended for use with the SmartSite® Needle Free Valve port or standard open female luers.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K053049: Alaris Safety Male Luer.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K053049

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026